Skip to content

A Validation Study of a Point-of-Care Nerve Conduction Device for the Quantitative Assesment of Chemotherapy-Induced Peripheral Neurotoxicity

A Validation Study of a Point-of-Care Nerve Conduction Device for the Quantitative Assesment of Chemotherapy-Induced Peripheral Neurotoxicity - A Validation Study of a Point-of-Care Nerve Conduction Device for the Quantitative Assesment of Chemotherapy-Induced Peripheral Neurotoxicity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016505
Enrollment
50
Registered
2015-02-10
Start date
2015-02-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Those who suffer from chemotherapy-induced peripheral neurotoxicity

Interventions

To measure the sural nerve sensory conduction verocity(SNCV) and sensory action potential(SNAP) by the point-of-care nerve conduction device (NC-stat)

Sponsors

Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients who have received chemotherapy and have suffred from CIPN (NCI-CTCAE ver4.0, Grade1, 2, 3) are included. All patients will have written informed consent.

Exclusion criteria

Exclusion criteria: Patients with pre-existing neuropathy, diabetes mellitus, alcoholic abuse or central nervous system metastasis are excluded.

Design outcomes

Primary

MeasureTime frame
Validation of the point-of-care nerve conduction device for the objective, quantitative assessment of CIPN

Secondary

MeasureTime frame
Correlation of the quantitative assesment of CIPN through the point-of-care nerve conduction device(NC-stat) with the qualitative assesment of CIPN through NCI-CTCAE ver4.0

Countries

Japan

Contacts

Public ContactAyumu Matsuoka

Nagoya University Hospital Department of Clinical Oncology and Chemotherapy

ayumu0611@med.nagoya-u.ac.jp052-744-1903

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026